N
CASI

Nuveen’s CASI Pharmaceuticals CASI Stock Holding History

Nuveen’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-28,308
Closed -$679K – 3385
2021
Q1 		$679K Buy
28,308
+4,804
+20% +$135K ﹤0.01% 3015
2020
Q4 		$693K Buy
23,504
+238
+1% +$5.17K ﹤0.01% 2929
2020
Q3 		$356K Buy
23,266
+5,099
+28% +$96K ﹤0.01% 3042
2020
Q2 		$455K Sell
18,167
-1,143
-6% -$24.8K ﹤0.01% 2936
2020
Q1 		$394K Buy
19,310
+17
+0.1% +$406 ﹤0.01% 2853
2019
Q4 		$596K Sell
19,293
-133
-0.7% -$4.31K ﹤0.01% 2865
2019
Q3 		$649K Sell
19,426
-1,076
-5% -$34.5K ﹤0.01% 2864
2019
Q2 		$656K Buy
+20,502
New +$655K ﹤0.01% 2909

Other funds holding CASI

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
IACGFIA
IDG-Accel China Growth Fund III Associates Hong Kong $31.2M AUM 2.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return
WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return